Shadi Hamoud | Heart diseases | Best Researcher Award

Posted on by ScienceFather

Dr. Shadi Hamoud | Heart diseases | Best Researcher Award

Head, research unit at Rambam Health Care Campus, Israel

Dr. Shadi Hamoud is a distinguished physician, researcher, and academic leader specializing in internal medicine, atherosclerosis, and novel cardiovascular treatments. With an MD (cum laude) from Hebrew University and an MPA from the University of Haifa, he serves as a Clinical Senior Lecturer at the Technion-Israel Institute of Technology and Deputy Director of Internal Medicine E at Rambam Medical Center. His research focuses on lipoproteins oxidation, heparanase enzyme roles in kidney and liver diseases, and international clinical trials on cardiovascular medicine, diabetes, and COVID-19 therapies. He has mentored numerous graduate students, contributed extensively to clinical research, and secured competitive research grants. His leadership extends to ethics committees, pharmaceutical consulting, and medical education. Recognized with multiple teaching excellence awards, he actively contributes to professional societies, public health initiatives, and medical advancements, making him a strong candidate for the Best Researcher Award. However, a broader international research collaboration could further enhance his impact.

Professional Profile

Education🎓

Dr. Shadi Hamoud holds an MD degree with cum laude honors from the Hebrew University of Jerusalem, demonstrating his strong academic foundation in medicine. He further pursued an Executive Master of Public Administration (MPA) at the University of Haifa, equipping him with leadership and administrative skills essential for medical research and healthcare management. Throughout his education, he developed a keen interest in internal medicine, atherosclerosis, and cardiovascular diseases, which later became the core of his research. His academic journey also includes specialized training in clinical research, medical ethics, and translational medicine, enhancing his expertise in both theoretical and practical aspects of healthcare. His commitment to continuous learning is evident in his involvement with international research projects and advanced training programs. His diverse educational background not only strengthens his medical proficiency but also enables him to contribute significantly to healthcare policy, medical education, and clinical advancements in cardiovascular and metabolic diseases.

Professional Experience 📝

Dr. Shadi Hamoud is a distinguished physician and researcher specializing in internal medicine, atherosclerosis, and cardiovascular diseases. He has extensive professional experience in clinical practice, medical research, and healthcare administration. As a senior physician, he has worked in leading hospitals, diagnosing and treating complex cardiovascular and metabolic disorders. His expertise extends to translational medicine, bridging the gap between research and patient care. Dr. Hamoud has also been actively involved in clinical trials, contributing to groundbreaking studies on lipid metabolism and atherosclerosis. His leadership roles in medical institutions and research committees reflect his dedication to advancing medical knowledge and improving patient outcomes. Additionally, he has collaborated with international experts, publishing numerous high-impact research papers in peer-reviewed journals. His commitment to medical education is evident through mentoring young researchers and medical students, ensuring the next generation of healthcare professionals is well-equipped to tackle emerging challenges in cardiovascular and metabolic diseases.

Research Interest🔎

Dr. Shadi Hamoud’s research interests focus on cardiovascular diseases, atherosclerosis, and lipid metabolism, with a particular emphasis on the mechanisms underlying cardiovascular risk factors. His work explores the role of cholesterol, inflammation, and metabolic disorders in the development of atherosclerosis, aiming to identify novel therapeutic targets for prevention and treatment. He is also deeply interested in translational medicine, bridging laboratory research with clinical applications to enhance patient care. Dr. Hamoud has contributed significantly to studies on lipid-lowering therapies, biomarkers for cardiovascular risk assessment, and the impact of lifestyle modifications on heart health. His research extends to the intersection of metabolic disorders such as diabetes and obesity with cardiovascular disease, seeking innovative strategies to reduce morbidity and mortality. Through collaborations with international research institutions, he continues to advance scientific understanding in cardiovascular medicine, striving to develop more effective diagnostic tools and personalized treatment approaches for patients with cardiovascular and metabolic diseases.

Award and Honor🏆

Dr. Shadi Hamoud has received numerous awards and honors in recognition of his outstanding contributions to cardiovascular research and medicine. His excellence in scientific innovation and dedication to improving cardiovascular health have earned him prestigious accolades from medical and research institutions worldwide. He has been honored with awards for his groundbreaking work in lipid metabolism and atherosclerosis, highlighting his impact on the field. Additionally, Dr. Hamoud has received research grants and fellowships that have supported his pioneering studies in cardiovascular disease prevention and treatment. His contributions have been recognized through invitations to speak at international conferences, where he has shared his expertise with the global medical community. He has also been acknowledged for his mentorship and leadership in guiding young researchers in the field. Through his achievements, Dr. Hamoud continues to make significant advancements in cardiovascular medicine, earning widespread recognition for his dedication to scientific excellence and patient care.

Research Skill🔬

Dr. Shadi Hamoud possesses exceptional research skills that have significantly advanced the field of cardiovascular medicine. His expertise spans a wide range of methodologies, including molecular biology techniques, lipid metabolism analysis, and advanced imaging technologies for cardiovascular assessment. He is proficient in designing and conducting clinical and laboratory-based studies, utilizing statistical tools to analyze complex datasets, and translating research findings into clinical applications. Dr. Hamoud excels in grant writing and securing research funding, demonstrating his ability to lead high-impact projects. His strong problem-solving skills and critical thinking enable him to address challenging scientific questions effectively. Additionally, his collaborative approach fosters interdisciplinary research, enhancing innovation in cardiovascular disease prevention and treatment. With a keen eye for detail and a commitment to scientific integrity, Dr. Hamoud consistently produces high-quality research that contributes to medical advancements, making him a highly respected figure in the scientific and medical communities.

Conclusion💡

Dr. Shadi Hamoud is a highly suitable candidate for the Best Researcher Award, given his exceptional contributions to cardiovascular research, clinical medicine, and medical education. His extensive mentorship, leadership in international clinical trials, and commitment to translational medicine make him a strong contender. Strengthening his global visibility and publishing more in top-tier journals could further enhance his profile.

Publications Top Noted✍️

  • Title: Potential Nephroprotective Effect of uPA against Ischemia/Reperfusion-Induced Acute Kidney Injury in αMUPA Mice and HEK-293 Cells
    Authors: H.A. Alkhaleq, Heba Abd; I. Hacker, Israel; T. Karram, Tony; A. Kabala, Aviva; Z.A. Abassi, Zaid A.
    Year: 2024

  • Title: Involvement of Heparanase in the Pathogenesis of Acute Pancreatitis: Implication of Novel Therapeutic Approaches
    Authors: D.B. Hamo-Giladi, Dalit B.; A. Fokra, Ahmad; E. Sabo, Edmond; Z.A. Abassi, Zaid A.; I. Khamaysi, Iyad
    Year: 2024

  • Title: Gender-Specific Renoprotective Pathways in αMUPA Transgenic Mice Subjected to Acute Kidney Injury
    Authors: H.A. Alkhaleq, Heba Abd; S. Hamoud, Shadi; I. Hacker, Israel; A. Kabala, Aviva; Z.A. Abassi, Zaid A.
    Year: 2024
    Citations: 2

 

Calver Pang | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. Calver Pang | Medicine and Dentistry | Best Researcher Award

Plastic Surgery Registrar at UCL, Division of Surgery & Interventional Science, United Kingdom

Dr. Calver Pang is an accomplished medical researcher and plastic surgery specialist with extensive experience in vascular malformations. He holds a PhD from University College London and has completed a prestigious surgical research fellowship at Johns Hopkins University. With multiple peer-reviewed publications and contributions to systematic reviews, his work has significantly influenced clinical practice, particularly in sclerotherapy and molecular pathogenesis. He has secured over £146,000 in research grants, including funding from The Butterfly AVM Charity and The Royal Free Charity. Recognized with several research awards, including the Qualitative Research Winner (Society of Academic & Research Society, 2020), he has demonstrated a strong commitment to advancing medical science. His multidisciplinary collaborations, spanning vascular and plastic surgery, pharmacology, and nanotechnology, highlight his innovative approach. While further leadership in large-scale trials could strengthen his profile, his impressive research achievements and clinical impact make him a strong contender for the Best Researcher Award.

Professional Profile 

Education

Dr. Calver Pang has a distinguished educational background spanning medicine, surgery, and pharmacology. He earned his MBChB from the University of Leicester in 2015, followed by Membership of the Royal College of Surgeons (MRCS) Edinburgh in 2021. He is currently pursuing a PhD at University College London (UCL), focusing on biomarkers in vascular malformations, demonstrating his commitment to advancing medical research. Additionally, he holds a First-Class Honours MPharm degree from UCL’s School of Pharmacy (2010), showcasing his strong foundation in both medicine and pharmacology. His dedication to medical education is further evident through his Associate Fellowship of the Higher Education Academy (AFHEA, 2021). Beyond formal education, he has completed multiple advanced surgical training courses, including ATLS, CCrISP, and EMSB, enhancing his expertise in trauma, critical care, and reconstructive surgery. His diverse academic qualifications highlight his interdisciplinary expertise, making him a well-rounded and accomplished researcher and clinician.

Professional Experience

Dr. Calver Pang has an extensive and diverse professional background in surgery and medical research. Currently, he is a Specialty Training (ST4) plastic surgery trainee at Cambridge University Hospitals (2024–2025), following his ST3 role in the same department. His expertise spans plastic, vascular, trauma, orthopaedic, and general surgery, having trained at prestigious institutions such as the Royal Free London NHS Foundation Trust, University Hospitals of Leicester, and Addenbrooke’s Hospital. His international experience includes a Surgical Research Fellowship at Johns Hopkins University (2015–2017), where he contributed to cutting-edge research in surgery. Additionally, he served as a Clinical Research Fellow at the Royal Free London NHS Trust (2017–2020), focusing on vascular malformations and gene therapy. His career reflects a strong balance between clinical excellence and research innovation, with leadership in multi-disciplinary studies and numerous high-impact publications. His expertise in both clinical practice and academia makes him a standout in his field.

Research Interest

Mr. Calver Pang’s research interests lie at the intersection of vascular malformations, plastic surgery, and regenerative medicine. His PhD at University College London focuses on the characterization of biomarkers in vascular malformations, aiming to improve diagnostic accuracy and treatment strategies. He has extensively studied embolotherapy, sclerotherapy, and molecular pathogenesis, contributing to advancements in minimally invasive interventions. His work also extends to gene therapy and nanotechnology in wound healing, demonstrating his innovative approach to translational medicine. He has published multiple peer-reviewed articles on mental health and quality of life in patients with congenital vascular disorders, emphasizing holistic patient care. Additionally, his interest in botulinum toxin therapy for vascular conditions showcases his commitment to pioneering new treatments. With a strong foundation in both clinical and laboratory-based research, he continues to explore novel therapies that bridge the gap between basic science and real-world medical applications, ultimately improving patient outcomes.

Award and Honor
Mr. Calver Pang has received numerous awards and honors in recognition of his outstanding contributions to medical research and surgery. He was awarded the Qualitative Research Winner by the Society of Academic & Research Society (2020) and the ASiT Virtual Event Bursary (2020), highlighting his excellence in academic research. He has secured multiple prestigious grants, including The Butterfly AVM Charity Grant (£136,080, 2019) and The Royal Free Charity Grant (£10,000, 2019), supporting his work in vascular malformations. His achievements also include the Robert Brown Travel Award from UCL (2019) and various elective scholarships, such as the British Medical and GlaxoSmithKline Dental Students’ Trust (£800, 2015) and the British Association of Plastic Reconstructive and Aesthetic Surgeons bursary (£500, 2015). His recognition at both national and international levels reflects his dedication to advancing medical science, making him a highly regarded researcher and clinician in his field.

Research Skill

Mr. Calver Pang possesses a diverse and advanced set of research skills, making him a distinguished medical researcher. He is highly proficient in clinical and translational research, with expertise in biomarker analysis, histopathology, and molecular pathogenesis of vascular malformations. His ability to design and conduct systematic reviews, multicenter studies, and observational research has led to numerous high-impact publications. He is skilled in statistical analysis, data interpretation, and research methodology, ensuring rigorous and evidence-based conclusions. His experience in grant writing and securing competitive funding—amounting to over £146,000 in research grants—demonstrates his ability to drive independent research projects. Additionally, he has experience in nanotechnology and gene therapy, applying innovative approaches to wound healing and regenerative medicine. His multidisciplinary collaborations across vascular surgery, plastic surgery, and pharmacology further enhance his research versatility. His analytical mindset and dedication to advancing medical knowledge make him a leading researcher in his field.

Conclusion

Mr. Calver Pang is a highly suitable candidate for the Best Researcher Award, with a strong research background, multiple grants, and impactful publications. His contributions to vascular malformation research and multidisciplinary approach set him apart. While he could further solidify his leadership with larger-scale studies and more high-impact journal publications, his current achievements make him a compelling contender for the award.

Publications Top Noted

  • Author(s): Pang, C., Iakovou, D., Fraser, D., Langridge, B.J., Butler, P.E.M.
  • Year: 2025
  • Title: A systematic review of botulinum toxin as a treatment for Raynaud’s disease secondary to scleroderma
  • Journal: Clinical Rheumatology

Lars Blønd | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. Lars Blønd | Medicine and Dentistry | Best Researcher Award

Senior Surgeon at Senior Surgeon, Denmark

Dr. Lars Blønd is a distinguished orthopedic surgeon and researcher specializing in patellofemoral surgery. As the inventor of the Arthroscopic Deepening Trochleoplasty, he has made groundbreaking contributions to knee and shoulder arthroscopy. With over 40 peer-reviewed publications, book chapters, and a dedicated book on femoral trochlear dysplasia, his research has significantly impacted the field. He has held leadership roles, including President of the Danish Association of Sports Medicine and ESSKA Scientific Committee member, demonstrating his influence in orthopedic research. Additionally, he actively educates and trains surgeons worldwide through live surgeries and instructional courses. His work bridges clinical practice and research, ensuring direct patient care improvements. While expanding his multidisciplinary collaborations could enhance his impact, his dedication to advancing orthopedic surgery and mentoring the next generation of researchers makes him a highly deserving candidate for the Best Researcher Award.

Professional Profile

Education

Dr. Lars Blønd’s educational journey reflects his commitment to excellence in medicine and orthopedic surgery. He graduated from gymnasium in 1981 before serving in the Danish Navy in 1982. He then pursued medical studies at the University of Copenhagen, earning his medical degree in 1991. Following this, he underwent extensive postgraduate training in orthopedic surgery across eight different hospitals between 1991 and 2002, ultimately becoming a certified specialist in orthopedic surgery in 2001. Furthering his expertise, he obtained a Certificate in Sports Medicine in 2003. His education laid the foundation for his specialization in arthroscopic surgery, particularly in knee and shoulder procedures. Throughout his career, Dr. Blønd has continued to refine his skills, engage in research, and contribute to advancements in patellofemoral surgery. His rigorous training, combined with years of hands-on experience, has established him as a leading figure in orthopedic surgery and medical education.

Professional Experience

Dr. Lars Blønd has an extensive and distinguished career in orthopedic surgery, specializing in arthroscopic procedures for the knee and shoulder. Since 2013, he has served as a senior surgeon at The Zealand University Hospital of Koege and Aleris Hospital while also working with the Danish Patient Safety Authority. Previously, he held leadership roles, including Chief Surgeon at GHP (2008–2013), Herlev University Hospital (2006–2008), and Gentofte University Hospital (2004–2006). His expertise extends to private healthcare, having worked as a consultant and chief surgeon at multiple private hospitals. Beyond clinical practice, he has contributed to sports medicine, serving as a team physician for the Superliga soccer team HB Køge FC. As an international educator, he has trained surgeons globally through live surgeries and instructional courses. His decades-long experience, leadership in orthopedic advancements, and dedication to patient care make him a highly respected figure in the field of orthopedic surgery.

Research Interest

Dr. Lars Blønd’s research primarily focuses on orthopedic surgery, with a strong emphasis on patellofemoral instability, knee biomechanics, and arthroscopic surgical techniques. He is widely recognized for his pioneering work in Arthroscopic Deepening Trochleoplasty, a procedure he developed to address trochlear dysplasia and recurrent patellar dislocations. His research explores innovative surgical methods to improve patient outcomes, including MPFL reconstruction, cartilage preservation, and treatment strategies for chronic anterior knee pain. Additionally, he has contributed to studies on sports-related injuries, exsanguination techniques, and advanced imaging for knee pathology assessment. His work also extends to regenerative medicine, particularly the use of adipose-derived stem cells for treating osteoarthritis. Through his numerous peer-reviewed publications, book chapters, and global conference presentations, Dr. Blønd has significantly advanced the understanding and treatment of knee conditions, making his research invaluable to the fields of orthopedic surgery and sports medicine.

Award and Honor

Dr. Lars Blønd has earned widespread recognition for his contributions to orthopedic surgery, particularly in the field of patellofemoral instability and arthroscopic procedures. While specific awards and honors are not explicitly listed, his leadership roles and memberships in esteemed medical societies, such as ESSKA and the Danish Society for Arthroscopic Surgery, highlight his influence and respect in the field. His pioneering work in developing the Arthroscopic Deepening Trochleoplasty technique has garnered international recognition, leading to invitations for live surgical demonstrations and educational courses worldwide. Additionally, his extensive contributions to medical literature, including over 40 peer-reviewed publications and multiple book chapters, demonstrate his scholarly impact. As a sought-after speaker at global conferences and a host for prestigious surgical training programs, Dr. Blønd’s work continues to shape modern orthopedic surgery. His dedication to research, education, and surgical innovation reflects the qualities of an esteemed medical professional worthy of high honors.

Research Skill

Dr. Lars Blønd possesses exceptional research skills, demonstrated by his extensive contributions to orthopedic literature and surgical innovation. With over 40 peer-reviewed publications, multiple book chapters, and a leading role in developing Arthroscopic Deepening Trochleoplasty, he has established himself as a key researcher in patellofemoral instability and knee biomechanics. His ability to conduct high-quality clinical studies, retrospective analyses, and surgical technique evaluations showcases his expertise in evidence-based medicine. Dr. Blønd’s research skills extend to advanced imaging interpretation, biomechanical assessments, and regenerative medicine, particularly in the use of adipose-derived stem cells for osteoarthritis treatment. His involvement in international research collaborations, editorial contributions, and live surgical demonstrations further highlights his analytical and problem-solving abilities. As a frequent speaker at global conferences and an educator in arthroscopic surgery, he integrates research with clinical practice, continuously advancing the field of orthopedic surgery through data-driven insights and innovative surgical approaches.

Conclusion

Dr. Lars Blønd is a highly suitable candidate for the Best Researcher Award. His extensive publication record, innovative surgical advancements, and contributions to orthopedic research and education make him a strong contender. While he could further expand his research scope and collaborations, his impact on patellofemoral surgery and sports medicine is undeniable, making him an exemplary researcher in his field.

Publications Top Noted

  • Exercise performance in elite male and female sailors
    Authors: Larsson, B., Beyer, N., Bay, P., Blønd, L., Aagaard, P., and Kjaer, M.
    Year: 1996
    Citation: Int. J Sports Med. 17: 504-508

  • Patellofemoral pain syndrome in athletes: a 5.7-year retrospective follow-up study of 250 athletes
    Authors: Blønd, L. and Hansen, L.
    Year: 1998
    Citation: Acta Orthop Belg. 64: 393-400

  • Injuries caused by falling soccer goalposts in Denmark
    Authors: Blønd, L. and Hansen, L. B.
    Year: 1999
    Citation: Br. J Sports Med. 33: 110-112

  • Scintigraphic method for evaluation of reductions in local blood volumes in human extremities
    Authors: Blønd, L. and Madsen, J.L.
    Year: 2000
    Citation: Scand J Lab Clin Inv. 60;(5): 333-339

  • Exsanguination of lower limbs before surgery
    Authors: Blønd, L., Kirketerp-Moeller K, Sonne-Holm S, and Madsen J.L.
    Year: 2002
    Citation: Acta Orthop Scand. 73;(1): 89-92

  • Exsanguination of upper limbs before surgery
    Authors: Blønd, L. and Madsen, J.L.
    Year: 2002
    Citation: JBJS (Br). 84;(4):489-491

  • Exsanguination of limbs in elderly before surgery: A comparison with young individuals
    Authors: Blønd, L. and Madsen, J.L.
    Year: 2003
    Citation: Int. Orthop. 27;(2): 114-116

  • Bone marrow perfusion in healthy subjects assessed by scintigraphy after application of a tourniquet
    Authors: Blønd, L. and Madsen, J.L.
    Year: 2003
    Citation: Acta Orthop Scand. 74;(4): 460-464

  • Tranexamic acid reduces blood loss and blood transfusion in primary total hip arthroplasty
    Authors: Husted H., Blønd L., Sonne-Holm S., Holm G., Jacobsen T., Gebuhr P.
    Year: 2003
    Citation: Acta Orthop Scand. 74;(6): 665-669

  • Clinical Consequences of Different Exsanguination Methods in Hand Surgery: A Double-blind Randomised Study
    Authors: Blønd L., Jensen NV., Søe-Nielsen NH.
    Year: 2008
    Citation: Journal of Hand Surgery (European Volume) 33; 475

  • Suprascapular Nerve Block or Interscalene Brachial Plexus Block for Pain Relief after Arthroscopic Acromioplasty
    Authors: Konradsen L., Kirkegaard PR., Larsen VH., Blønd L.
    Year: 2009
    Citation: Ambulatory Surgery 15-1

  • The arthroscopic deepening trochleoplasty
    Authors: Blønd L. and Schöttle P.
    Year: 2010
    Citation: Knee Surg Sports Traumatol Arthrosc 18(4):480-5

  • Development in sports medicine
    Authors: Blønd L.
    Year: 2012
    Citation: Ugeskr Laeger 174(12):783

  • Arthroscopic treatment for snapping scapula: a prospective case series
    Authors: Blønd L., & Rechter S.
    Year: 2014
    Citation: Eur J Orthop Surg & Traumatol 24(2):159-64

  • Combined arthroscopic deepening trochleoplasty and reconstruction of the medial patellofemoral ligament for patients with recurrent patella dislocation and trochlear dysplasia
    Authors: Blønd L., & Haugegaard M.
    Year: 2014
    Citation: Knee Surg Sports Traumatol Arthrosc 22:2484–2490